Regenerative Medical Technology (RMTG) Retained Earnings (2017 - 2025)
Historic Retained Earnings for Regenerative Medical Technology (RMTG) over the last 9 years, with Q3 2025 value amounting to -$74.0 million.
- Regenerative Medical Technology's Retained Earnings fell 1054.74% to -$74.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$74.0 million, marking a year-over-year decrease of 1054.74%. This contributed to the annual value of -$67.6 million for FY2024, which is 897.4% down from last year.
- Latest data reveals that Regenerative Medical Technology reported Retained Earnings of -$74.0 million as of Q3 2025, which was down 1054.74% from -$69.6 million recorded in Q2 2025.
- In the past 5 years, Regenerative Medical Technology's Retained Earnings registered a high of -$34.3 million during Q1 2021, and its lowest value of -$74.0 million during Q3 2025.
- Moreover, its 5-year median value for Retained Earnings was -$55.9 million (2023), whereas its average is -$56.5 million.
- Per our database at Business Quant, Regenerative Medical Technology's Retained Earnings plummeted by 4165.62% in 2022 and then crashed by 543.89% in 2025.
- Regenerative Medical Technology's Retained Earnings (Quarter) stood at -$46.7 million in 2021, then dropped by 11.8% to -$52.2 million in 2022, then decreased by 18.81% to -$62.0 million in 2023, then decreased by 8.97% to -$67.6 million in 2024, then decreased by 9.5% to -$74.0 million in 2025.
- Its last three reported values are -$74.0 million in Q3 2025, -$69.6 million for Q2 2025, and -$68.3 million during Q1 2025.